| A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers JK Sabari, M Offin, D Stephens, A Ni, A Lee, N Pavlakis, S Clarke, ... JNCI: Journal of the National Cancer Institute 111 (6), 575-583, 2019 | 121 | 2019 |
| Screening for ROS1 gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this … CI Selinger, BT Li, N Pavlakis, M Links, AJ Gill, A Lee, S Clarke, TN Tran, ... Histopathology 70 (3), 402-411, 2017 | 63 | 2017 |
| Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer J Jee, ES Lebow, R Yeh, JP Das, A Namakydoust, PK Paik, JE Chaft, ... Nature medicine 28 (11), 2353-2363, 2022 | 58 | 2022 |
| Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label … M Khasraw, A Lee, S McCowatt, Z Kerestes, ME Buyse, M Back, ... Journal of Neuro-oncology 128, 163-171, 2016 | 44 | 2016 |
| Validation of the 8th edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy K van Gysen, M Stevens, L Guo, D Jayamanne, D Veivers, A Wignall, ... BMC cancer 19, 1-8, 2019 | 41 | 2019 |
| Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis VM Lu, A Goyal, RA Rovin, A Lee, KL McDonald Journal of neuro-oncology 141, 1-12, 2019 | 40 | 2019 |
| MesomiR 1: a phase I study of TargomiRs in patients with refractory malignant pleural mesothelioma (MPM) and lung cancer (NSCLC) N van Zandwijk, N Pavlakis, S Kao, S Clarke, A Lee, H Brahmbhatt, ... Annals of Oncology 26, ii16, 2015 | 39 | 2015 |
| Anti‐epidermal growth factor receptor therapy for glioblastoma in adults A Lee, M Arasaratnam, DLH Chan, M Khasraw, VM Howell, H Wheeler Cochrane Database of Systematic Reviews, 2020 | 36 | 2020 |
| HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib BT Li, A Lee, S O’Toole, W Cooper, B Yu, JE Chaft, ME Arcila, MG Kris, ... Lung Cancer 90 (3), 617-619, 2015 | 36 | 2015 |
| The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis VM Lu, A Goyal, A Lee, M Jentoft, A Quinones-Hinojosa, KL Chaichana Journal of neuro-oncology 142, 1-10, 2019 | 34 | 2019 |
| A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer M Alexander, N Pavlakis, T John, R O’Connell, S Kao, BGM Hughes, ... Lung Cancer 142, 34-40, 2020 | 31 | 2020 |
| Systematic review and meta-analysis on the role of chemotherapy in advanced and metastatic neuroendocrine tumor (NET) MH Wong, DL Chan, A Lee, BT Li, S Lumba, SJ Clarke, J Samra, ... PLoS One 11 (6), e0158140, 2016 | 27 | 2016 |
| Systematic review of the role of targeted therapy in metastatic neuroendocrine tumors A Lee, DL Chan, MH Wong, BT Li, S Lumba, SJ Clarke, J Samra, ... Neuroendocrinology 104 (3), 209-222, 2017 | 26 | 2017 |
| Malignant cardiac tamponade from non-small cell lung cancer: case series from the era of molecular targeted therapy BT Li, A Pearson, N Pavlakis, D Bell, A Lee, D Chan, M Harden, M Mathur, ... Journal of Clinical Medicine 4 (1), 75-84, 2014 | 20 | 2014 |
| Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions S Mondaca, ES Lebow, A Namakydoust, P Razavi, JS Reis-Filho, R Shen, ... Lung Cancer 159, 66-73, 2021 | 18 | 2021 |
| The intertwined fates of inflammation and coagulation in glioma A Cho, KJ McKelvey, A Lee, AL Hudson Mammalian genome 29 (11), 806-816, 2018 | 17 | 2018 |
| The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials BT Li, TA Barnes, DL Chan, J Naidoo, A Lee, M Khasraw, GM Marx, ... Lung Cancer 102, 21-27, 2016 | 13 | 2016 |
| Intensity‐modulated radiotherapy using simultaneous‐integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single … M Johnston, L Guo, M Back, A Guminski, A Lee, C Hanna, D Veivers, ... Journal of Medical Imaging and Radiation Oncology 57 (3), 356-363, 2013 | 13 | 2013 |
| Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT) L Emmett, N John, S Pathmanandavel, W Counter, M Ayers, S Sharma, ... Therapeutic Advances in Medical Oncology 15, 17588359231156392, 2023 | 12 | 2023 |
| Complete response in a patient with stage IV adrenocortical carcinoma treated with adjuvant trans‐catheter arterial chemo‐embolization (TACE) E Wong, S Jacques, M Bennett, V Gorolay, A Lee, S Clarke Asia‐Pacific Journal of Clinical Oncology 14 (3), 279-281, 2018 | 11 | 2018 |
Stephen ClarkeProfessor of Medicine, University of Sydney and Medical Oncologist, RNSH and Genesis CareVerified email at sydney.edu.au
